Counselors in Leadville, CO Accepting Medicare
7 Counselors found. Showing 1 - 7
 Elizabeth Levasseur Counselor Medicare: Not Enrolled in Medicare Practice Location: 714 Front St, Leadville, CO 80461 Phone: 719-486-0985 Fax: 719-486-0986 |
Camille Ness Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 714 Front St, Leadville, CO 80461 Phone: 605-890-1625 |
Lauren Saathoff, LCPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 714 Front St, Leadville, CO 80461 Phone: 719-486-0985 |
Katherine L Omerigic Counselor Medicare: Not Enrolled in Medicare Practice Location: 714 Front St, Leadville, CO 80461 Phone: 719-486-0985 Fax: 719-486-0986 |
Mandy J Kaisner, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 714 Front St, Leadville, CO 80461 Phone: 719-486-0985 Fax: 719-486-0986 |
Teresa Michelle Haynes, PSYCHOLOGIST Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: Leadville Professional Building, 735 Hwy 24 South, Suite B, Leadville, CO 80461 Phone: 970-389-0621 |
Mary Katherine Connell Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1713 Mount Lincoln Dr W, Leadville, CO 80461 Phone: 970-564-7439 |
News Archive
PARP inhibitor can successfully treat a subset of advanced prostate cancer patients
Results from an international clinical trial found that men with advanced prostate cancer who have mutated BRCA1/BRCA2 genes can be treated successfully with a targeted therapy known as rucaparib, resulting in recent FDA approval.
Health Canada announces labelling update for Cipralex
Health Canada is informing Canadians of a labelling update for the prescription drug Cipralex (the brand name of the drug escitalopram) regarding a dose-related risk of abnormal heart rhythms. Cipralex is used to treat depression and belongs to a family of drugs known as Selective Serotonin Reuptake Inhibitors (SSRIs).
Link found between bisphenol A and heart disease
British scientists have revealed a possible link between the chemical bisphenol A (BPA) and disease in adults.
NIH clinical trial evaluates antiviral plus anti-inflammatory drug for COVID-19
A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019 (COVID-19) has begun.
› Verified 7 days ago
Counselors
Dentists
Clinical Social Workers
Occupational Therapists
Pharmacists